论文部分内容阅读
硫普罗宁商品名凯西莱,是近年来用于临床的新药,我们于1997年4月开始在门诊部、肝病科与结核科的临床应用。至97年底,共用药84例病人,现将资料完整的68例总结报告如下:1.临床资料1.1 病例资料:凡自1997年4月开始在我院就诊,化验肝功能异常,不论门诊或住院治疗的病人,凡志愿应用该药者均列为观察对象。共登记观察84例,资料完整的68例,其中男38例,女30例,年龄15岁以下8例,15—35岁22例,35—55岁组18例,55—75岁组14例,75岁以上2例,临床诊断属于急性传染性肝炎48例(其中乙肝活动期26例,抗结核药物引起肝损害14例,酒精中毒性肝损害2例,早期肝硬化4例,肝功化验
Thiopronin, brand name Cassi Lai, is a new drug used clinically in recent years. We started clinical application in outpatient department, liver department and tuberculosis department in April 1997. To the end of 1997, a total of 84 patients with medication, the data now complete 68 cases are summarized as follows: 1 clinical data 1.1 case information: where since April 1997 in our hospital, laboratory liver function abnormalities, regardless of outpatient or inpatient Treatment of patients, who voluntarily apply the drug were included in the observation. A total of 84 cases were enrolled in the study and 68 cases were complete with data, including 38 males and 30 females, 8 under 15 years of age, 22 cases of 15-35 years old, 18 cases of 35-55 years old and 14 cases of 55-75 years old , 2 cases over the age of 75, clinical diagnosis of 48 cases of acute infectious hepatitis (including 26 cases of hepatitis B active stage, 14 cases of liver damage caused by anti-TB drugs, alcoholic liver damage in 2 cases, 4 cases of early liver cirrhosis, liver function test